In the study performed by Maier et al., PITX2 DNA methylation showed the strongest correlation with metastasis-free survival in N0 ER/PR+, tamoxifen-treated breast cancer patients, with high PITX2 DNA methylation representing poor metastasis-free survival [51]. The gene discussed is PITX2; the disease is breast carcinoma.